Clinical Trial Update: ROAR-DIGAP: A Widely Inclusive, Largely Virtual Pilot Trial Utilizing DIGAP (Deep Integrated Genomics Analysis Platform) To Personalize Treatments [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ROAR-DIGAP, a Duke University pilot study using the Deep Integrated Genomics Analysis Platform to personalize treatments for a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Snippet

Sponsor: Duke University | Conditions: Amyotrophic Lateral Sclerosis ALS | Phase 2 | Status: COMPLETED